1. Cannabidiol improves maternal obesity-induced behavioral, neuroinflammatory and neurochemical dysfunctions in the juvenile offspring.
- Author
-
da Silva Rodrigues, Fernanda, Jantsch, Jeferson, de Farias Fraga, Gabriel, Luiza de Camargo Milczarski, Vitória, Silva Dias, Victor, Scheid, Camila, de Oliveira Merib, Josias, Giovernardi, Marcia, and Padilha Guedes, Renata
- Subjects
- *
SOCIAL anxiety , *CANNABIDIOL , *COMPULSIVE eating , *OXYTOCIN receptors , *AUTISM spectrum disorders , *DOPAMINE receptors , *METABOLIC disorders , *22Q11 deletion syndrome , *OBESITY - Abstract
• Maternal obesity alters the neurological and behavioral phenotype in the offspring. • Treatment with cannabidiol rescues anxiety and social disturbances in the offspring. • Both perinatal maternal obesity and CBD present sexually dimorphic influences. • CBD modulates glial reactivity, oxytocin, glutamate and endocannabinoid signaling. Maternal obesity is associated with an increased risk of psychiatric disorders such as anxiety, depression, schizophrenia and autism spectrum disorder in the offspring. While numerous studies focus on preventive measures targeting the mothers, only a limited number provide practical approaches for addressing the damages once they are already established. We have recently demonstrated the interplay between maternal obesity and treatment with cannabidiol (CBD) on hypothalamic inflammation and metabolic disturbances, however, little is known about this relationship on behavioral manifestations and neurochemical imbalances in other brain regions. Therefore, here we tested whether CBD treatment could mitigate anxiety-like and social behavioral alterations, as well as neurochemical disruptions in both male and female offspring of obese dams. Female Wistar rats were fed a cafeteria diet for 12 weeks prior to mating, and during gestation and lactation. Offspring received CBD (50 mg/kg) from weaning for 3 weeks. Behavioral tests assessed anxiety-like manifestations and social behavior, while neuroinflammatory and neurochemical markers were evaluated in the prefrontal cortex (PFC) and hippocampus. CBD treatment attenuated maternal obesity-induced anxiety-like and social behavioral alterations, followed by rescuing effects on imbalanced neurotransmitter and endocannabinoid concentrations and altered expression of glial markers, CB1, oxytocin and dopamine receptors, with important differences between sexes. Overall, the findings of this study provide insight into the signaling pathways for the therapeutic benefits of CBD on neuroinflammation and neurochemical imbalances caused by perinatal maternal obesity in the PFC and the hippocampus, which translates into the behavioral manifestations, highlighting the sexual dimorphism encompassing both the transgenerational effect of obesity and the endocannabinoid system. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF